{"organizations": [], "uuid": "8da7f7bc496ad528aee4010cc3bd40ad2af3db24", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/22/the-associated-press-caredx-reports-4q-loss.html", "country": "US", "domain_rank": 767, "title": "CareDx reports 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T23:25:00.000+02:00", "replies_count": 0, "uuid": "8da7f7bc496ad528aee4010cc3bd40ad2af3db24"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/22/the-associated-press-caredx-reports-4q-loss.html", "ord_in_thread": 0, "title": "CareDx reports 4Q loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "calif.", "sentiment": "none"}, {"name": "brisbane", "sentiment": "none"}, {"name": "brisbane", "sentiment": "none"}], "organizations": [{"name": "caredx inc.", "sentiment": "negative"}, {"name": "cdna", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}, {"name": "caredx", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BRISBANE, Calif. (AP) _ CareDx Inc. (CDNA) on Thursday reported a loss of $31.7 million in its fourth quarter.\nOn a per-share basis, the Brisbane, California-based company said it had a loss of $1.13. Losses, adjusted for non-recurring costs and stock option expense, came to 9 cents per share.\nThe molecular diagnostics company posted revenue of $12.5 million in the period.\nFor the year, the company reported that its loss widened to $55.5 million, or $2.38 per share. Revenue was reported as $48.3 million.\nCareDx expects full-year revenue in the range of $61 million to $63 million.\nCareDx shares have decreased 19 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.98, more than quadrupling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA", "external_links": [], "published": "2018-03-22T23:25:00.000+02:00", "crawled": "2018-03-23T01:12:37.069+02:00", "highlightTitle": ""}